ACS Omega · 2020 · 74 citations · 39 references
PharmacyPharmaceutical AnalysisPharmacologyAnalytical ChemistryChromatographic AnalysisMass Spectrometric AnalysisAnalytical ChromatographyChromatographic Data AnalysisChromatographyMass SpectrometryMedicinal PlantsMetabolite ExtractionBioactive Plant CompoundsConcentrationExtractFragmentationFragmentation Pattern AnalysisHerbal Drug AnalysisHigh-performance Liquid ChromatographyMass Spectral Fragmentation
> 0.99) for all 11 compounds within the tested concentration ranges. The limits of detection and quantification were in the range of 0.213-0.362 and 0.646-1.098 μg/mL, respectively. The results were precise (relative standard deviation, <5.0%) and accurate (relative error, 0.01-0.76). All compounds showed good recoveries of 84.77-100.11%. For the first time, withanoside VII, 27-hydroxywithanone, dihydrowithaferin A, and viscosalactone B were quantified and validated along with bioactive compounds withanoside IV, withanoside V, withaferin A, 12-deoxywithastramonolide, withanolide A, withanone, and withanolide B simultaneously in WS. This UHPLC-PDA method has practical adaptability for ashwagandha raw material, extract, and product manufacturers, along with basic and applied science researchers. The method has been developed on UHPLC for routine analysis. The 11 withanosides and withanolides were confirmed using the fragmentation pattern obtained by the combined use of electrospray ionization and collision-induced dissociation in triple-quadrupole tandem mass spectrometry (TQ-MS/MS) in the WSE.
39
International Conference on Harmonization (ICH)
Jen‐pei Liu, Shein‐Chung Chow · 2018 · 427 citations
Pharmacy, International Law, International Organizations +10
Immunomodulatory activity of Withania somnifera
Leemol Davis, Girija Kuttan · Journal of Ethnopharmacology · 2000 · 320 citations
Hisashi Matsuda, Toshiyuki Murakami, Akinobu Kishi et al. · Bioorganic & Medicinal Chemistry · 2001 · 219 citations